Guidelines on the management of tuberculosis and HIV infection in the United Kingdom. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.
出版信息
BMJ. 1992 May 9;304(6836):1231-3. doi: 10.1136/bmj.304.6836.1231.
Abstract
摘要
相似文献
1
Guidelines on the management of tuberculosis and HIV infection in the United Kingdom. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.
BMJ. 1992 May 9;304(6836):1231-3. doi: 10.1136/bmj.304.6836.1231.
2
Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society.
Thorax. 2000 Nov;55(11):887-901. doi: 10.1136/thorax.55.11.887.
3
Control and prevention of tuberculosis in Britain: an updated code of practice. Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society.
BMJ. 1990 Apr 14;300(6730):995-9. doi: 10.1136/bmj.300.6730.995.
4
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 1994. Joint Tuberculosis Committee of the British Thoracic Society.
Thorax. 1994 Dec;49(12):1193-200. doi: 10.1136/thx.49.12.1193.
5
Disseminated BCG in HIV infection.
Arch Dis Child. 1988 Oct;63(10):1268-9. doi: 10.1136/adc.63.10.1268.
6
Chemotherapy and management of tuberculosis in the United Kingdom: recommendations of the Joint Tuberculosis Committee of the British Thoracic Society.
Thorax. 1990 May;45(5):403-8. doi: 10.1136/thx.45.5.403.
7
Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome.
MMWR Morb Mortal Wkly Rep. 1985 Apr 26;34(16):227-8.
8
BCG vaccination and AIDS.
Bull Int Union Tuberc Lung Dis. 1988 Dec;63(4):40-1.
9
10
[HIV-infection, AIDS and BCG vaccination].
Kekkaku. 1993 Jun;68(6):435-44.
引用本文的文献
1
Pharmacokinetic factors in the modern drug treatment of tuberculosis.
Clin Pharmacokinet. 1999 Aug;37(2):127-46. doi: 10.2165/00003088-199937020-00003.
2
Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations.
Clin Pharmacokinet. 1997 Mar;32(3):194-209. doi: 10.2165/00003088-199732030-00003.
本文引用的文献
1
Interaction of ketoconazole with rifampin and isoniazid.
N Engl J Med. 1984 Dec 27;311(26):1681-3. doi: 10.1056/NEJM198412273112606.
2
The effects of the AIDS epidemic on the tuberculosis problem and tuberculosis programmes.
Bull Int Union Tuberc Lung Dis. 1988 Jun;63(2):21-4.
3
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
N Engl J Med. 1989 Mar 2;320(9):545-50. doi: 10.1056/NEJM198903023200901.
4
Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection.
JAMA. 1989 Jan 20;261(3):393-7.
5
Tuberculosis in the United States.
JAMA. 1989 Jul 21;262(3):385-9.
6
Diagnosis of deep-vein thrombosis.
Lancet. 1989 Jul 1;2(8653):23-4.
7
Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.
Ann Intern Med. 1990 Sep 1;113(5):358-61. doi: 10.7326/0003-4819-113-5-358.
8
Drug interactions with fluconazole.
Rev Infect Dis. 1990 Mar-Apr;12 Suppl 3:S327-33. doi: 10.1093/clinids/12.supplement_3.s327.
9
Quadruple-drug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients.
J Infect Dis. 1990 Apr;161(4):801-5. doi: 10.1093/infdis/161.4.801.
10
Tuberculosis in patients with human immunodeficiency virus infection.
N Engl J Med. 1991 Jun 6;324(23):1644-50. doi: 10.1056/NEJM199106063242307.
Zotero 插件